dihexa hgf c-met potentiator Frontiers The HGF/c-Met Axis: A Promising
The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Positive Modulation of HGF MET by Fosgonimeton. Hypothesized fast onset Download Scientific Diagram Noncoding Microdeletion in Mouse Hgf Disrupts Neural Crest Migration into the Stria Vascularis, Reduces the Endocochlear Potential, and Suggests the Neuropathology for Human Nonsyndromic Deafness DFNB39 Journal of Neuroscience HGF c MET: A Promising Therapeutic Target in the Digestive System Cancers
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



